The anti-tumor activity of an anti-CD39 antibody (ES002) in a multiple myeloma model is dependent on NK cells

被引：0
|
作者：
Qiu, Yangsheng [1 ]
Du, Qinglin [1 ]
Sun, Meiling [1 ]
Gao, Rui [1 ]
Kong, Huimin [1 ]
Xing, Roumei [1 ]
Shi, Yufei [1 ]
Xu, Mengying [1 ]
Wu, Zhihao [1 ]
Lu, Hongtao [1 ]
机构：
[1] Elpisci Biopharma, Shanghai, Peoples R China
来源：
JOURNAL FOR IMMUNOTHERAPY OF CANCER | 2019年 / 7卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
P790
引用
收藏
页数：1
相关论文
共 50 条
  • [31] CD8+CD39+T Cells Mediate Anti-Tumor Cytotoxicity in Bladder Cancer
    Zhu, Wenjie
    Zhao, Zihan
    Feng, Baofu
    Yu, Wenhao
    Li, Ji
    Guo, Hongqian
    Yang, Rong
    ONCOTARGETS AND THERAPY, 2021, 14 : 2149 - 2161
  • [32] Targeting EZH2 in Multiple Myeloma-Multifaceted Anti-Tumor Activity
    Alzrigat, Mohammad
    Jernberg-Wiklund, Helena
    Licht, Jonathan D.
    EPIGENOMES, 2018, 2 (03)
  • [33] A monoclonal antibody specific for free human kappa light chains induces apoptosis of multiple myeloma cells and exhibits anti-tumor activity in vivo
    Asvadi, P
    Jones, DR
    Dunn, RD
    Choo, ABH
    Raison, MJ
    Raison, RL
    BLOOD, 2004, 104 (11) : 664A - 664A
  • [34] Mir-29a Displays in Vitro and in Vivo Anti-Tumor Activity in Multiple Myeloma
    Saha, Manujendra N.
    Chen, Yan
    Abdi, Jahangir
    Chang, Hong
    BLOOD, 2014, 124 (21)
  • [35] Biological pathways and in vivo anti-tumor activity induced by atiprimod in multiple myeloma (MM).
    Neri, Paola
    Tassone, Pierfrancesco
    Shammas, Masood
    Yasui, Hiroshi
    Schipani, Ernestina
    Batchu, Ramesh B.
    Blotta, Simona
    Prabhala, Rao
    Catley, Laurence
    Hamasaki, Makoto
    Hideshima, Teru
    Chauhan, Dharminder
    Jacob, Gary S.
    Picker, Donald
    Venuta, Salvatore
    Anderson, Kenneth C.
    Munshi, Nilchil C.
    BLOOD, 2006, 108 (11) : 986A - 986A
  • [36] Anti-tumor activity of a novel immunosuppressant FTY720 in multiple myeloma.
    Yasui, H
    Hideshima, T
    Roccaro, AM
    Shiraishi, N
    Hamasaki, M
    Ishitsuka, K
    Kumar, S
    Raje, N
    Li, GL
    Tai, YT
    Podar, K
    Chauhan, D
    Anderson, KC
    BLOOD, 2004, 104 (11) : 941A - 942A
  • [37] Anti-tumor activity of lysophosphatidic acid acyltransferase (LPAAT)-β inhibitors in multiple myeloma (MM).
    Hideshima, T
    Chauhan, D
    Hayashi, T
    Podar, K
    Akiyama, M
    Mitsiades, C
    Mitsiades, N
    Gong, BQ
    Bonham, L
    de Vries, P
    Munshi, NC
    Richardson, PG
    Singer, JW
    Anderson, KC
    BLOOD, 2003, 102 (11) : 451A - 452A
  • [38] TIGIT BLOCKADE IMPROVES ANTI-TUMOR ACTIVITY OF EX VIVO EXPANDED NK CELLS
    Hasan, Md Faqrul
    Copik, Alicja
    JOURNAL FOR IMMUNOTHERAPY OF CANCER, 2021, 9 : A718 - A718
  • [39] SOT101 induces NK cell cytotoxicity and potentiates antibody-dependent cell cytotoxicity and anti-tumor activity
    Antosova, Zuzana
    Podzimkova, Nada
    Tomala, Jakub
    Augustynkova, Katerina
    Sajnerova, Katerina
    Nedvedova, Eva
    Sirova, Milada
    de Martynoff, Guy
    Bechard, David
    Moebius, Ulrich
    Kovar, Marek
    Spisek, Radek
    Adkins, Irena
    FRONTIERS IN IMMUNOLOGY, 2022, 13
  • [40] IL-15 has innate anti-tumor activity independent of NK and CD8 T cells
    Davies, Elizabeth
    Reid, Sarah
    Medina, Maria Fe
    Lichty, Brian
    Ashkar, Ali A.
    JOURNAL OF LEUKOCYTE BIOLOGY, 2010, 88 (03) : 529 - 536
12345